Hepion Pharmaceuticals Stock Quote HEPA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.532

Bid

0.53

Ask

0.60

Volume

208

0.00 Day's Range 0.00

0.4777 52 Week Range 3.72

Market Cap

3.702M

Previous Close

0.56

Open

Last Trade

128

0.532

(formt)

Last Trade Time

08:45:59

Financial Volume

VWAP

Average Volume (3m)

44,096

Shares Outstanding

6,958,371

Dividend Yield

PE Ratio

-0.08

Earnings Per Share (EPS)

-7.03

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was $0.56. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of $ 0.4777 to $ 3.72.

Hepion Pharmaceuticals currently has 6,958,371 shares outstanding. The market capitalization of Hepion Pharmaceuticals is $3.90 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.08.

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Form 425 - Prospectuses and communications, business combinations

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0663	-11.0813972923	0.5983	0.63	0.4815	24632	0.5556572	CS
4	-0.168	-24	0.7	0.72	0.4777	27222	0.60709287	CS
12	-0.128	-19.3939393939	0.66	0.89	0.4777	44096	0.69222522	CS
26	-0.528	-49.8113207547	1.06	1.12	0.4777	97434	0.77675955	CS
52	-2.988	-84.8863636364	3.52	3.72	0.4777	78648	1.29228488	CS
156	-23.468	-97.7833333333	24	27.8	0.4777	227284	14.23407895	CS
260	-100.068	-99.4711729622	100.6	150	0.4777	889824	40.8516951	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is $ 0.532

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 3.9M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of $ 0.4777 to $ 3.72 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.08

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BPTHBio Path Holdings Inc	$ 2.78 (315.55%)	52.74M
PRFXPainReform Ltd	$ 6.30 (190.32%)	19.1M
CURRCurrenc Group Inc	$ 5.48 (174.00%)	7.76M
APCXAppTech Payments Corporation	$ 0.9301 (144.12%)	61.82M
XHGXChange TED Inc	$ 1.62 (114.85%)	9.58M
LITMSnow Lake Resources Ltd	$ 0.437 (-46.67%)	11.23M
AEMDAethlon Medical Inc	$ 0.4399 (-33.41%)	3.1M
LGHLWLion Group Holding Ltd	$ 0.0061 (-31.46%)	2.18k
ESGEiShares Inc iShares ESG Aware MSCI EM ETF	$ 25.43 (-24.02%)	1.61k
PLRZPolyrizon Ltd	$ 2.50 (-24.01%)	489.01k
APCXAppTech Payments Corporation	$ 0.9301 (144.12%)	61.82M
BPTHBio Path Holdings Inc	$ 2.78 (315.55%)	52.74M
PRFXPainReform Ltd	$ 6.30 (190.32%)	19.1M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.3589 (-1.62%)	12.66M
LITMSnow Lake Resources Ltd	$ 0.437 (-46.67%)	11.23M